Antimicrobial Resistance Surveillance Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How Has the Antimicrobial Resistance Surveillance Market Growth Performance Trended Historically, And What Lies Ahead?
The market size of antimicrobial resistance surveillance has seen robust growth in the past years. The market is projected to expand from $6.77 billion in 2024 to $7.36 billion in 2025, with a compound annual growth rate (CAGR) of 8.7%. The historical growth is linked to the rise in antibiotic usage in farming, excessive prescribing of antibiotics in healthcare, insufficient diagnostic testing, below par infection prevention and control measures, as well as global tourism and commerce.
Expectations for robust expansion in the antimicrobial resistance surveillance market are high in the coming years, with projections estimating it to reach $10.18 billion in 2029, flaunting a compound annual growth rate (CAGR) of 8.5%. The predicted growth during this period is largely due to increased consciousness of antimicrobial resistance, advancements in diagnostic technology sophistication, heightened government initiatives and funding, a surge in in healthcare-related infections, and the creation of new antibiotics and alternatives. Key trends earmarked for the forecast period encapsulate the use of artificial intelligence in data analysis, the advent of next-generation sequencing technologies, the implementation of real-time surveillance systems, molecular diagnostic instruments, and the fusion of big data and machine learning in predictive modeling.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21100&type=smp
What Are the Core Market Drivers Propelling Growth in the Antimicrobial Resistance Surveillance Industry?
The growth of the antimicrobial resistance surveillance market is expected to be driven by the rising occurrence of infectious diseases. These ailments originate from harmful microorganisms like bacteria, viruses, fungi or parasites, which can be transmitted directly or indirectly amongst individuals. Factors like climate change, urbanization, and global travel are contributing to the heightened prevalence of infectious diseases, as they increase the spread of pathogens and expose humans to new microbes. Antimicrobial resistance surveillance plays a key role in tracking the proliferation of resistant pathogens, crafting effective treatment plans, and shaping public health policies to tackle infectious diseases. For example, a report by the UK Health Security Agency, a governmental entity in the UK, stated in February 2024 that tuberculosis (TB) cases in England had surged by 10.7% in 2023 when 4,850 cases were documented as opposed to 4,380 in 2022. Thus, the escalation in infectious diseases prevalence is catalyzing the growth of the antimicrobial resistance surveillance market.
How Is the Antimicrobial Resistance Surveillance Market Segmented?
The antimicrobial resistance surveillance market covered in this report is segmented –
1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications
3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users
Subsegments:
1) By Diagnostic Kits: PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits
2) By Diagnostic Systems: Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems
3) By Surveillance Software: Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems
4) By Services: Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21100&type=smp
Which Regions Are Driving the Next Phase of the Antimicrobial Resistance Surveillance Market Growth?
North America was the largest region in the antimicrobial resistance surveillance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance surveillance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Antimicrobial Resistance Surveillance Industry?
Leading firms in the market are focusing their efforts on cutting-edge technologies such as innovative diagnostic tools. These tools can streamline operations, boost efficiency, increase accuracy, decrease costs, and deliver enhanced results for both patients and end users. A diagnostic tool is a tool, software, or method used to identify, detect, or evaluate a condition, disease, or problem. For example, Sysmex Astrego AB, a Sweden-based company that manufactures and provides services for diagnostic products, announced in June 2023 the introduction of their PA-100 AST Point-of-Care Testing System. This system can quickly and accurately identify antimicrobial resistance at the care point, significantly reducing the time taken by conventional lab methods, which can span several days. By giving results in just half an hour, it enables healthcare professionals to make expedient and informed treatment decisions for infections, reducing the dependence on broad-spectrum antibiotics and contributing to the fight against antimicrobial resistance.
View the full report here:
How Is the Antimicrobial Resistance Surveillance Market Defined and What Are Its Core Parameters?
Antimicrobial resistance (AMR) surveillance refers to the systematic monitoring and tracking of the prevalence and spread of antimicrobial-resistant microorganisms. They are used for detecting emerging resistance patterns, guiding public health interventions, and informing treatment strategies to combat infections caused by resistant bacteria, viruses, and fungi.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21100
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
